Patent details

EP1242061 Title: USE OF BIOACTIVE METABOLITES OF GEPIRONE FOR THE MANUFACTURE OF A MEDICAMENT FOR THE TREATMENT OF PSYCHOLOGICAL DISORDERS

Basic Information

Publication number:
EP1242061
PCT Application Number:
PCT/US/2000/034131
Type:
European Patent Granted for LU
Legal Status:
Expired
Application number:
EP009864497
PCT Publication Number:
WO/2001/045687
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
USE OF BIOACTIVE METABOLITES OF GEPIRONE FOR THE MANUFACTURE OF A MEDICAMENT FOR THE TREATMENT OF PSYCHOLOGICAL DISORDERS
French Title of Invention:
UTILISATION DE METABOLITES DE GEPIRONE POUR LA FABRICATION D'UN MEDICAMENT POUR LE TRAITEMENT DE TROUBLES PSYCHOLOGIQUES
German Title of Invention:
VERWENDUNG VON GEPIRONE METABOLITE ZUR ERSTELLUNGS EINES MEDICAMENTS ZUR BEHANDLUNG VON NEUROLOGISCHER KRANKHEITEN
SPC Number:

Dates

Filing date:
18/12/2000
Grant date:
04/05/2005
EP Publication Date:
04/05/2005
PCT Publication Date:
28/06/2001
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
25/09/2002
EP B1 Publication Date:
04/05/2005
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
18/12/2020
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
18/12/2000
 
 

Name:
Fabre-Kramer Pharmaceuticals Inc.
Address:
Suite 3147, 5847 San Felipe, Houston, TX 77057, United States (US)

Agent

Name:
OFFICE FREYLINGER S.A.
From:
20/07/2005
Address:
PO Box 48, 8001, STRASSEN, Luxembourg (LU)
To:

Inventor

1

Name:
KRAMER Stephen, J.
Address:
United States (US)

2

Name:
YEVICH Joseph P.
Address:
United States (US)

3

Name:
FABRE Louis, F.
Address:
United States (US)

Priority

1

Priority Number:
172684 P
Priority Date:
20/12/1999
Priority Country:
United States (US)

2

Priority Number:
709741
Priority Date:
13/11/2000
Priority Country:
United States (US)

Classification

Main IPC Class:
A61K 31/00;

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
24/12/2019
Last Annual Fee Paid Number:
20
Last Annual Fee Paid Amount:
300 Euro
Payer:
CPA GLOBAL THE IP PLATFORM
Filing date Document type Number of pages